Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00488514
Status:
COMPLETED
Last Update Posted:
2017-05-18
First Post:
2007-06-18
Brief Title:
Long-Term Safety of Treximet SumatriptanNaproxen Sodium for Migraine in Adolescents
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
Study TXA107977 a Long-Term Safety Study of a Combination Product Containing Sumatriptan Succinate and Naproxen Sodium for the Treatment of Migraine in Adolescents
Status:
COMPLETED
Status Verified Date:
2016-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study was designed to determine long-term safety of TREXIMET sumatriptannaproxen sodium in adolescents for the acute treatment of migraine
Detailed Description:
This study was designed to determine long-term safety of TREXIMET sumatriptannaproxen sodium in adolescents aged 12 to 17 years for the acute treatment of migraine
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None